ライフサイエンスコーパス: psychiatric symptom

1 no between-group differences in severity of psychiatric symptoms.

2 abrupt onset of seizures and/or movement and psychiatric symptoms.

3 behaviors and their impairments give rise to psychiatric symptoms.

4 ly developing group and the group with other psychiatric symptoms.

5 tem, which could affect the brain and induce psychiatric symptoms.

6 ic effect in causing both motor and specific psychiatric symptoms.

7 xes, occasionally spasticity, and frequently psychiatric symptoms.

8 s no longer significant after adjustment for psychiatric symptoms.

9 on positive group to 27 of whom 21 (77%) had psychiatric symptoms.

10 ay underlie other aspects of functioning and psychiatric symptoms.

11 , core autism symptomatology, and associated psychiatric symptoms.

12 d had significantly improved functioning and psychiatric symptoms.

13 ng with the treatment regimen as a result of psychiatric symptoms.

14 how mind and brain work together to produce psychiatric symptoms.

15 f a deleterious association between lead and psychiatric symptoms.

16 s, lead was nonsignificantly associated with psychiatric symptoms.

17 nigmatic relationships between dizziness and psychiatric symptoms.

18 iginous dizziness, subjective imbalance, and psychiatric symptoms.

19 abuse, by themselves and in combination, on psychiatric symptoms.

20 th hepatic disease, neurological disease, or psychiatric symptoms.

21 imprinted gene that is often associated with psychiatric symptoms.

22 with PTSD, substance use disorder, and other psychiatric symptoms.

23 nd often presents with cognitive decline and psychiatric symptoms.

24 l, or dysmorphic conditions co-occurred with psychiatric symptoms.

25 rlie the frequent comorbidity of colonic and psychiatric symptoms.

26 Negative Syndrome Scale was used to measure psychiatric symptoms.

27 nd structured interview measures of PTSD and psychiatric symptoms.

28 reater impairment) than did patients with no psychiatric symptoms.

29 tes were randomly selected for screening for psychiatric symptoms.

30 stand the pathways that link genetic risk to psychiatric symptoms.

31 -acting, and long-lasting treatment for some psychiatric symptoms.

32 e evaluations and dimensional assessments of psychiatric symptoms.

33 ioral alterations, including memory loss and psychiatric symptoms.

34 ease characterized by cognitive deficits and psychiatric symptoms.

35 k for psychosis and perhaps other classes of psychiatric symptoms.

36 ircuit function to precipitate or exacerbate psychiatric symptoms.

37 the neurobiological alterations involved in psychiatric symptoms.

38 r effectiveness, side effects, and impact on psychiatric symptoms.

39 tanding fluctuations in emotional memory and psychiatric symptoms.

40 by diseases exhibiting comorbid visceral and psychiatric symptoms.

41 can induce distinct behavioral outcomes and psychiatric symptoms.

42 system to fully address either individual's psychiatric symptoms.

43 ot specific to working memory abnormality or psychiatric symptoms.

44 ss and trauma, leading to increased risk for psychiatric symptoms.

45 presents one of the earliest and most common psychiatric symptoms.

46 significant after controlling for concurrent psychiatric symptoms.

47 s were associated with both self and partner psychiatric symptoms.

48 donepezil and rivastigmine for cognitive and psychiatric symptoms.

49 w they may be influencing the development of psychiatric symptoms.

50 atients had cognitive deficits, 20 (83%) had psychiatric symptoms, 14 (58%) had insomnia, 12 (50%) ha

51 cannabis were more likely to be due to acute psychiatric symptoms (18.0% vs. 10.9%), intoxication (48

52 While 55.2% reported no psychiatric symptoms, 39.2% and 26.3% reported symptoms

53 sistently poor and ex-poor children had more psychiatric symptoms (4.38 and 4.28, respectively) than

54 als, but was more frequently associated with psychiatric symptoms (58 [25%] vs 34 [15%]) and weight g

55 ome carriers of the translocation who had no psychiatric symptoms-a pattern found in other families w

56 view for DSM-III-R; level of functioning and psychiatric symptoms according to the Global Assessment

57 In nearly all cases, there were early psychiatric symptoms after a median period of 6 months a

58 elve women (14-44 years) developed prominent psychiatric symptoms, amnesia, seizures, frequent dyskin

59 This study examined the prevalence of psychiatric symptoms among residents/workers in Manhatta

60 tates and eating disorders are comorbid with psychiatric symptoms and altered emotional responses.

61 c steroid (AAS) use has been associated with psychiatric symptoms and cognitive deficits, yet we have

62 The degree to which people with psychiatric symptoms and cognitive dysfunction can provi

63 were used to assess the relationship between psychiatric symptoms and cognitive function.

64 ons require adaptation in this group because psychiatric symptoms and cognitive impairment are highly

65 The influence of psychiatric symptoms and cognitive impairment on daily l

66 Psychiatric symptoms and cognitive performance were not

67 dy well-documented phenotypic comorbidity of psychiatric symptoms and diagnoses, which can be indexed

68 The relationship between psychiatric symptoms and disability in refugee survivors

69 eable risk factors in influencing adolescent psychiatric symptoms and disorders.

70 giosity are not strongly related to risk for psychiatric symptoms and disorders.

71 with having been tested before, more severe psychiatric symptoms and drug problems, level of worry a

72 d withdrawal-effects amplified in those with psychiatric symptoms and drug use coping motives.

73 s well its relationship to substance-induced psychiatric symptoms and drug use patterns.

74 cipants every 4 months for 2 years to assess psychiatric symptoms and functional status, and we colle

75 The authors examined the changes in psychiatric symptoms and global functioning in children

76 njection drug, and alcohol use.Reductions in psychiatric symptoms and hospitalizations are important

77 mechanisms through which genes contribute to psychiatric symptoms and how pharmacological and psychol

78 on is achieved are associated with decreased psychiatric symptoms and improved functioning in the off

79 en steroid abuse is associated with multiple psychiatric symptoms and is a significant public health

80 ated the association between lead burden and psychiatric symptoms and its potential modification by a

81 eductions in associated eating disorders and psychiatric symptoms and maintenance of gains through fo

82 alopathy, although the latter can also cause psychiatric symptoms and movement disorders.

83 Using large-scale online assessment of psychiatric symptoms and neurocognitive performance in t

84 eimer's disease but who manifest significant psychiatric symptoms and neuroleptic-induced extrapy-ram

85 ine the relationship of estrogen levels with psychiatric symptoms and neuropsychological function in

86 this investigation was to determine whether psychiatric symptoms and other characteristics of the in

87 Furthermore, psychiatric symptoms and psychosocial risk factors have

88 Dissociation may be a critical mediator of psychiatric symptoms and risk-taking behavior among sexu

89 Cognitive therapy significantly reduced psychiatric symptoms and seems to be a safe and acceptab

90 antibodies includes dominant behavioural and psychiatric symptoms and seizures that often interfere w

91 history of stressful life events, 4) current psychiatric symptoms and substance use, and 5) lifetime

92 Psychiatric symptoms and ward behaviors were assessed up

93 vels of alcohol use, injection drug use, and psychiatric symptoms and were one-fifth as likely as tho

94 981 participants endorsing significant other psychiatric symptoms and with 1963 typically developing

95 need for obstetricians to assess history of psychiatric symptoms and, with pediatric and psychiatric

96 ency between model animal behavior and human psychiatric symptoms, and 3) the possibility that model

97 in terms of neuropsychological functioning, psychiatric symptoms, and ability to provide informed co

98 diagnosis, including sleep disorders, falls, psychiatric symptoms, and autonomic dysfunctions.

99 ifests with progressive motor abnormalities, psychiatric symptoms, and cognitive decline.

100 is prevalent, especially among children with psychiatric symptoms, and constitutes a major concern wo

101 e relationships among cognitive dysfunction, psychiatric symptoms, and decisional capacity.

102 ent attendance, drug use, cigarette smoking, psychiatric symptoms, and HIV-risk behavior.

103 Poor visual acuity, presence of psychiatric symptoms, and less satisfaction with vision

104 involuntary movements, extrapyramidal signs, psychiatric symptoms, and medical and drug treatment his

105 Results were similar in patients without psychiatric symptoms, and the increased risk persisted i

106 scores (PRS) and a broad range of childhood psychiatric symptoms, and to quantify the extent to whic

107 programs, experienced greater reductions in psychiatric symptoms, and were more satisfied with their

108 ated with altered neural processing and with psychiatric symptom (anxiety) in humans, which provides

109 Psychiatric symptoms are a consistent early clinical fea

110 Psychiatric symptoms are a significant aspect of Hunting

111 sentations, and the frequent assumption that psychiatric symptoms are an inherent part of the underly

112 rmalities and corresponding neurological and psychiatric symptoms are frequently observed in lysosoma

113 system leading to cognitive, autonomic, and psychiatric symptoms are not sufficiently treated by cur

114 Childhood psychiatric symptoms are often diffuse but can coalesce

115 the neurobiological factors contributing to psychiatric symptoms are poorly understood.

116 These results indicate that once psychiatric symptoms are present in patients with Alzhei

117 Psychiatric symptoms are prominent in the initial presen

118 ng the 3 medication groups in improvement of psychiatric symptoms as measured by the PANSS total scor

119 Comprehensive measures of PTSD and psychiatric symptoms, as well as social functioning, wer

120 mechanistic insights into the cognitive and psychiatric symptoms associated with a schizophrenia-pre

121 for dystonia-associated genes indicates that psychiatric symptoms associated with dystonia are likely

122 een assumed to underlie the neurological and psychiatric symptoms associated with neurodevelopmental

123 e adjusted by sex, family factors, and child psychiatric symptoms at 8 years of age, we found indepen

124 ed-effects regression models, differences in psychiatric symptoms at baseline and over time between t

125 dwelling elderly adults who had nonpsychotic psychiatric symptoms at baseline.

126 The presence of psychiatric symptoms at presentation was a better discri

127 to 7 had a rate of psychotic, but not other psychiatric, symptoms at age 23 that was nearly seven ti

128 tends these findings by examining changes in psychiatric symptoms, behavioral problems, and functioni

129 velopment may underlie differential risk for psychiatric symptoms between males and females.

130 differences in emotional responses and many psychiatric symptoms between males and females.

131 fferences were not explained by nonpsychotic psychiatric symptom burden, multimorbidity, or substance

132 ication compliance was associated with fewer psychiatric symptoms but not with better housing placeme

133 icant reductions in substance use, PTSD, and psychiatric symptoms, but community care participants wo

134 est whether systematic patterns of change in psychiatric symptoms can be recovered across weekly asse

135 learning difficulties and seizures and later psychiatric symptoms, cerebellar ataxia, extrapyramidal

136 selective serotonin reuptake inhibitors for psychiatric symptoms, cholinesterase inhibitors for cogn

137 At V1, all psychiatric symptom clusters were similarly altered in p

138 in other diseases where motor, cognitive and psychiatric symptoms co-exist.

139 Relationships among psychiatric symptoms, cognitive function, and daily livi

140 Furthermore, psychiatric symptoms confer risk of dependence, and copi

141 maternal depression severity and children's psychiatric symptoms continued to decrease over time.

142 Psychiatric symptoms correlated positively with each oth

143 Clinicians should be aware that serious psychiatric symptoms could be associated with ephedra us

144 relationship between religiosity and current psychiatric symptoms, current substance use, lifetime ps

145 ssed mother's symptoms remit, her children's psychiatric symptoms decrease.

146 Psychiatric symptoms decreased significantly only in chi

147 patients with 22q11.2DS to manage associated psychiatric symptoms delayed diagnosis of PD by up to 10

148 eview introduces a classification scheme for psychiatric symptoms, describing them in terms of the st

149 id arthritis in whom subacute neurologic and psychiatric symptoms developed after 3 years of treatmen

150 Outcome of limb weakness, physical and psychiatric symptoms, disability/quality of life and ill

151 Analysis of the psychiatric symptoms does not suggest specific features

152 sociated with quantitative measures of broad psychiatric symptom domains and cognitive functioning.

153 r, the relationship between HM and different psychiatric symptoms domains is not well understood.

154 cal basis for and complex interactions among psychiatric symptoms, drug exposure history, and addicti

155 s of topology of tau lesions with late-onset psychiatric symptoms due to TBI have not been explored.

156 eptococcal infections present with motor and psychiatric symptoms, due to basal ganglia involvement.

157 olescence or early adulthood after age, sex, psychiatric symptoms during childhood and early adolesce

158 identifying the patients at highest risk for psychiatric symptoms during recovery.

159 ophrenia, neuropsychological functioning and psychiatric symptoms (e.g., apathy and avolition), but n

160 Less well appreciated are the psychiatric symptoms experienced by many PD patients, in

161 and, unlike girls, had no reduction in total psychiatric symptoms following foster placement.

162 omes with prominent, and sometimes isolated, psychiatric symptoms for which patients are fi rst seen

163 Longitudinal measures for up to 10 years of psychiatric symptoms from the Symptom Checklist-90-Revis

164 Additional measures were other psychiatric symptoms, functional status, quality of life

165 nversely related to the magnitude of initial psychiatric symptoms (Hamilton Depression Scale: r = -0.

166 s and atypical presentations, including pure psychiatric symptoms, has shifted scientific interest ba

167 Prominent behavioral and psychiatric symptoms have been recognized since these di

168 struments designed to collect information on psychiatric symptoms, health, and possible postdeploymen

169 In addition, their psychiatric symptoms, history of suicide attempts, and o

170 with reductions in use of other substances, psychiatric symptoms, HIV risk behavior, and inpatient s

171 and lives of people suffering from specific psychiatric symptoms, illnesses, and/or disabilities.

172 ata extraction were different neurologic and psychiatric symptoms, imaging results, and age at onset

173 arning task together with measures of common psychiatric symptoms in 400 subjects.

174 ustly predict general cognitive function and psychiatric symptoms in a large and well-characterized d

175 autonomic reactivity to trauma reminders and psychiatric symptoms in adults who had some degree of di

176 as working memory, is crucial to addressing psychiatric symptoms in brain disorders.

177 relationship between GMV in the left OFC and psychiatric symptoms in CM, we observed a negative assoc

178 rify the neuropathological substrates of key psychiatric symptoms in dementia with Lewy bodies.

179 ly provide insight into the origins of these psychiatric symptoms in dementia.

180 explanation for many of the neurological and psychiatric symptoms in FXS.

181 ted with increased risk of the corresponding psychiatric symptoms in HD, suggesting a common genetic

182 and apathy appears to be distinct from other psychiatric symptoms in HD.

183 may be effective at treating effort-related psychiatric symptoms in humans.

184 ting aberrations in amygdala connectivity to psychiatric symptoms in individual patients.

185 in DISC1 and the delayed onset of a range of psychiatric symptoms in late adolescence.

186 ad to cognitive decline, motor deficits, and psychiatric symptoms in patients with Huntington disease

187 cognitive therapy was effective in reducing psychiatric symptoms in people with schizophrenia spectr

188 Little is known about the impact of comorbid psychiatric symptoms in persons with HIV.

189 r CB(1)R binding is related to cognitive and psychiatric symptoms in pre-HD mutation carriers.

190 n the two diagnoses, but the contribution of psychiatric symptoms in primary insomnia appears to be a

191 AP as a useful biomarker for the severity of psychiatric symptoms in response to psychological stress

192 ess because they often present with comorbid psychiatric symptoms in the absence of identifiable vest

193 The robust associations with psychiatric symptoms in the age range when these typical

194 Manual of Mental Disorders, Fourth Edition, psychiatric symptoms in the never-poor, persistently poo

195 mutation carriers already have cognitive and psychiatric symptoms in the premanifest (premotor) phase

196 Children's psychiatric symptoms in the STAR*D-Child study were asse

197 ed by the presence of other neurological and psychiatric symptoms in this group of conditions.

198 The acute onset of severe atypical psychiatric symptoms in young female patients should rai

199 m deficits in association with dimensions of psychiatric symptoms in youth using a working memory par

200 t steps in efforts to parse heterogeneity in psychiatric symptoms in youths by identifying abnormalit

201 ington disease (HD) is associated with early psychiatric symptoms including anxiety and depression.

202 Female carriers had psychiatric symptoms, including generalized anxiety, dep

203 Rather, it was the presence of psychiatric symptoms, including psychosis and agitation,

204 t systematic detection and treatment of core psychiatric symptoms, including psychotic and impulsivit

205 also carried this mutation but did not have psychiatric symptoms, indicating that this mutation has

206 l participants and used to obtain convergent psychiatric symptom information for additional first-deg

207 The authors group behavioral and psychiatric symptoms into psychotic features, agitated f

208 monitoring task and were assessed on current psychiatric symptoms, IQ, and frontal lobe functioning.

209 nce suggests that fetal exposure to maternal psychiatric symptoms is associated with future risk for

210 sure to bullying in the absence of childhood psychiatric symptoms is associated with psychiatric outc

211 o bullying, even in the absence of childhood psychiatric symptoms, is associated with severe adulthoo

212 interventions was a barrier for people with psychiatric symptoms, low premorbid intelligence quotien

213 lateral sclerosis (ALS) patient kindreds and psychiatric symptoms may precede the onset of motor symp

214 Across all psychiatric symptoms measured, one multivariate brain-be

215 g brain, leading to complex neurological and psychiatric symptoms observed in fetal alcohol spectrum

216 Psychiatric symptoms occurred in two thirds of acute res

217 nd link a potential function of DISC1 to the psychiatric symptoms of AD.

218 There was a significant improvement in the psychiatric symptoms of individuals who were seropositiv

219 gulation, altered stress hormone levels, and psychiatric symptoms of stress-related mental illnesses.

220 that some patients with rapidly progressive psychiatric symptoms or cognitive impairment, seizures,

221 wide trauma may be different from changes in psychiatric symptoms or general distress after such even

222 he two groups did not differ with respect to psychiatric symptoms or hospitalizations.

223 All patients presented with psychiatric symptoms or memory problems; 76 had seizures

224 There was very little change in patients' psychiatric symptoms or social behavior problems.

225 aze palsy, rhythmic myoclonus, dementia with psychiatric symptoms, or hypothalamic manifestations).

226 Psychiatric symptoms play a crucial role in psychology a

227 itish birth cohort) underwent assessments of psychiatric symptoms, primarily anxiety and depression,

228 t from other types of depression in terms of psychiatric symptom profile and treatment response.

229 ly, there was no evidence of exacerbation of psychiatric symptoms, psychosis, depression, or suicidal

230 Ratings of cannabis use and psychiatric symptoms (psychotic, negative, disorganized,

231 Psychiatric symptoms, quality of life, scores on the Per

232 e used to determine the associations between psychiatric symptom ratings and quantitative anatomic an

233 ere were no significant treatment effects on psychiatric symptom ratings or psychiatric adverse event

234 High rates of debt and psychiatric symptoms related to gambling, including anxi

235 In addition to relapse prevention and psychiatric symptom relief, the benefits of antipsychoti

236 the association of ambient temperature with psychiatric symptoms remains poorly understood.

237 support aversive learning relate to specific psychiatric symptoms remains undetermined.

238 gs indicate that in a young woman with acute psychiatric symptoms, seizures, and central hypoventilat

239 report four young women who developed acute psychiatric symptoms, seizures, memory deficits, decreas

240 a 26% (95% CI=7%-44%) greater improvement in psychiatric symptom severity compared with standard case

241 cortisol secretion and multiple measures of psychiatric symptom severity were also collected on all.

242 with life, neurobehavioral symptom severity, psychiatric symptom severity, and sleep impairment were

243 mary care clinicians who detect subthreshold psychiatric symptoms should consider a broad psychiatric

244 s (N=131) who had been annually assessed for psychiatric symptoms since ages 3-5 years.

245 hosocial and functioning measures, including psychiatric symptoms, social interactions, quality of li

246 ed aspects of motivation are associated with psychiatric symptoms such as anergia, fatigue, lassitude

247 ications, and more alcohol-related emotional/psychiatric symptoms such as depression and anxiety.

248 Prior studies indicate psychiatric symptoms such as depression, apathy and anxi

249 characterized by comorbidity of colonic and psychiatric symptoms, such as irritable bowel syndrome.

250 likely to have prominent speech-related and psychiatric symptoms than patients with classic disease

251 the complexities of evaluating and treating psychiatric symptoms that are concurrent with a seizure

252 mmon and results in several neurological and psychiatric symptoms that are poorly linked to standard

253 In addition, 50 (43%) of the mothers had psychiatric symptoms that did not meet the diagnostic th

254 The authors define 6 groups of subthreshold psychiatric symptoms that do not meet the full criteria

255 ut extrapyramidal symptoms or signs also had psychiatric symptoms that might be related to their carr

256 ase of a woman in her late 30s who developed psychiatric symptoms that progressed to encephalopathy,

257 sive learning processes in the expression of psychiatric symptoms that transcend diagnostic boundarie

258 tempts before treatment may reflect emerging psychiatric symptoms that trigger medical consultations

259 However, as for many other psychiatric symptoms the biological mechanisms underlyin

260 Among patients with psychiatric symptoms, the CASSY performed better than th

261 environmental perturbations that exacerbate psychiatric symptoms themselves.

262 Because of their psychiatric symptoms, they often are unlikely to receive

263 h histories of mood disorders reported their psychiatric symptoms to a medical provider, a substantia

264 ulation study with data on social habits and psychiatric symptoms to compare prevalences of depressio

265 any relationship between brain pathology and psychiatric symptoms, true natural disease entities may

266 manner, with onset of motor, cognitive, and psychiatric symptoms typically occurring in midlife, fol

267 We linked computational parameters to psychiatric symptoms using canonical correlation analysi

268 up these children at age 12 years to assess psychiatric symptoms using the Diagnostic Interview Sche

269 nterview for Substance and Mental Disorders; psychiatric symptoms using the Positive and Negative Syn

270 The relationships of persistent psychiatric symptoms (visual hallucinations, delusions,

271 athology of 505 (46%) patients with reported psychiatric symptoms was described in more detailed term

272 The occurrence of psychiatric symptoms was reported over 1 month.

273 Age, but not psychiatric symptoms, was predictive of objective insomn

274 nts and abnormalities of voluntary movement, psychiatric symptoms, weight loss, dementia, and a relen

275 Psychiatric symptoms were assessed and average estrogen

276 Psychiatric symptoms were assessed through the Positive

277 Psychiatric symptoms were assessed using the Brief Sympt

278 MAIN OUTCOME MEASURES: Psychiatric symptoms were assessed using the Preschool A

279 Psychiatric symptoms were assessed with the Beck Depress

280 re years of education, white race, and fewer psychiatric symptoms were associated with being in the g

281 owing data: 1) whether changes in children's psychiatric symptoms were associated with changes in the

282 hildhood and early adolescence, and parental psychiatric symptoms were controlled statistically.

283 Psychiatric symptoms were evaluated by using the Hospita

284 Differences in psychiatric symptoms were evaluated using longitudinal r

285 Rates of clinically significant psychiatric symptoms were high, equally prevalent in pat

286 Psychiatric symptoms were measured with the parent-rated

287 Changes in psychiatric symptoms were measured with the Positive and

288 Correlations of hormone levels with psychiatric symptoms were nonsignificant.

289 on about bullying, exposure to bullying, and psychiatric symptoms were obtained from parents, teacher

290 These baseline psychiatric symptoms were of similar or greater magnitud

291 y enrolled, participants with high levels of psychiatric symptoms were oversampled for follow-up.

292 Healthy women with no gastrointestinal or psychiatric symptoms were randomly assigned to groups gi

293 Decreases in the number of children's psychiatric symptoms were significantly associated with

294 Own psychological resilience factors and psychiatric symptoms were strongly correlated for both p

295 measured by the LPP, predispose children to psychiatric symptoms when exposed to higher levels of st

296 n the ICU were significantly associated with psychiatric symptoms, whereas greater severity of illnes

297 ntions are beneficial in reducing iatrogenic psychiatric symptoms while allowing patients to maintain

298 he co-occurrence of various neurological and psychiatric symptoms with DD, including mood disorders,

299 ers, disabling relationship difficulties, or psychiatric symptoms without associated impairment.

300 type of isolated psychiatric episodes (pure psychiatric symptoms without neurological involvement) e